Global Endoscopic Visualization System Market Research Report
- Report Code: EN 1000
- Publish Date: Upcoming
The global endoscopy visualization equipment market, mainly driven by favorable reimbursements in select geographies, growing aging population, and increasing prevalence/incidence of diseases requiring endoscopy procedures, was valued at $11.3 million in 2013, and expected to be $15.3 million by 2018. It is projected to grow at a CAGR of 6.4%.
The report ‘Endoscopy Visualization Equipment Market forecast, 2008-2018’ analyzes the market of devices by segments such as endoscopic cameras, video processors, video converters, camera heads, endoscopic light sources, transmitters & receivers, and wireless displays and monitors. With a market value of $2.02 billion and $1.71 billion, wireless displays and monitors and others visualization devices segments have been contributing 18.3% and 15.5% respectively in terms of the total global endoscopy visualization equipment market. All of these segments experienced a positive growth with an increased awareness of patients and physicians towards the usage and reception of new endoscopy technologies, due to the numerous advantages offered by these devices.
The demand for endoscopy visualization equipment has increased significantly, largely because of patients’ preference for minimally invasive surgeries. Endoscopic procedures are low-risk procedures and are easily covered by health insurance. A pivotal factor that propels the growth of the endoscopy visualization equipment market is the rapid rise in the number of elderly people who are prone to orthopedic, gastrointestinal, and ophthalmic, diseases as well as cancer. As per the World Health Organization (WHO), between 2000 and 2050, the proportion of the world's population that is aged 60 years will double from about 11% to 22%. This aging population is the main end user of knee-hip implants, bariatric surgeries, gastrointestinal endoscopy, and colonoscopy procedures. With the growing number of elderly people, age-related ailments are also expected to rise sharply, thus propelling the demand and consumption of endoscopy devices concomitantly.
The number of people in the world who are obese or overweight has reached 2.1 billion, from 875 million in 1980. Furthermore, approximately 7 million people in the United States have some symptoms of Gastroesophageal Reflux Disorder (GERD). Primary or secondary GERD diagnosis increased from a total of 995,402 individuals diagnosed in 1998 to 3,141,965 in 2005. 4.2% of all people hospitalized with GERD in 2005 also had an esophageal disorder. In the United States, 1,150 deaths in 2004 were directly related to a primary diagnosis of GERD.
North America accounted for the highest share of the global endoscopy visualization equipment devices market followed by Europe, and Asia. North America and Europe both are likely to witness a demand for endoscopes as a result of technological advancements as well as improved reimbursement status in both the geographies. Rapidly aging population, increased obesity rates, and growing incidence of associated disease are some of the major factors driving the European endoscopy visualization equipment market.
Ageing, chronically ill population, increasing affluence, increasing number of private sector hospitals, advancements in endoscopic technology, and expansion to rural healthcare facilities are also going to play a pivotal role in boosting the demand for endoscopy visualization equipment in the Asian region. China and India will be the focal point for growth of endoscopy visualization equipment in the Asian market.
The endoscopy visualization equipment market in the rest of the world is expected to grow at a fast pace due to improved reimbursement coverage, increasing government healthcare spending, as well as increasing awareness levels of patients regarding minimally invasive surgeries.
The report also provides an extensive competitive landscaping of companies operating in endoscopy visualization equipment market. The key players in this segment are Stryker Corporation, Olympus Corporation, Covidien Plc, Arthrex, Inc.,Karl Storz, ConMed, Hoya Corporation, Medivators, and Solos Endoscopy.
Segment and country specific company shares, news & deals, mergers and acquisitions, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed.
Customization Options
Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment wise)
- Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment wise and country wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Epidemiology Data
- Country specific prevalence of cancer, gastrointestinal tract disorders, gastroesophageal reflux disorder (GERD), gynecological disorders
- Country specific patient pool of cancer, gastrointestinal tract disorders, gastroesophageal reflux disorder (GERD), gynecological disorders
- Disease progression (pattern analysis)
Procedure Volume Data
- Different types of endoscopy visualization equipment procedures performed annually in each country tracked till sub- segment level
- Number of abdominal, gastro intestinal, interior of joints, gynecology, bronchology, and large & small intestinal procedures performed in each country
Surgeons/Physicians Perception Analysis
- Fast turn-around analysis of Surgeons’ response to market events and trends
- Surgeons’ opinion about products from different companies
- Surgeons’ qualitative inputs on epidemiology date
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Pricing Trends
- Cost analysis of endoscopy visualization equipment in various countries
- Abdominal, gastro intestinal, interior of joints, gynecology, bronchology, and large and small intestinal procedural investment in major countries
Competitive Intelligence
- The company share analysis of endoscopy visualization equipment for the top players of the market in the region
- The crucial developments and strategies of companies inculcating in their portfolio for endoscopy visualization equipment
Alternative Products: Impact analysis
MMM’s healthcare decision making quadrant is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and cancer centers, reimbursement scenario, diagnosis rate, treatment rate, and healthcare expenditure).
1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Segments
4.1 Video Processor
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Endoscopic Visualization System Market The North American endoscopy visualization equipment market, mainly driven by favorable reimbursements in select geographies, growing aging population, and increasing prevalence/incidence of diseases requiring endoscopy procedures, was valued at $4.5 million in 2013 and is expected to reach $6.3 million by 2018, growing at a CAGR of 6.6% during the forecast period. The report on this market analyzes the market by segments that include endoscopic cameras, video processors, video converters, camera heads, endoscopic light sources, transmitters and receivers, wireless displays and monitors, and other visualization devices. The key players in this market are Stryker Corporation, Ethicon Endo-Surgery, Inc., Olympus Corporation, Covidien plc, Arthrex, Inc., Smiths Group plc, Aesculap, Inc., ConMed Corporation, Richard Wolf GmbH, Hoya Corporation, and Fujifilm Holdings Corporation. |
Upcoming |
|
|
European Endoscopic Visualization System Market The European Endoscopy Visualization Equipment Market is mainly driven by favorable reimbursements in select geographies, growing aging population, and increasing prevalence/incidence of diseases requiring endoscopy procedures. It was pegged at $2.93 billion in 2013 and expected to be $3.83 billion by 2018, growing at a CAGR of 5.5%. The Endoscopy Visualization Equipment Market analyzes the market segments such as Endoscopic Cameras, Video Processors, Video Converters, Camera Heads, endoscopic light sources, transmitters & receivers, wireless displays and monitors, Others visualization devices. The prominent players are Stryker Corporation, Ethicon Endo-Surgery, Inc, Olympus Corporation, Covidien Plc, Boston Scientific, Arthrex, Inc., Smiths Group, Aesculap, Inc, Karl Storz, ConMed, Richard Wolf GmbH, HOYA CORPORATION and Fujifilm Holdings Corporation. |
Upcoming |
|
|
Asian Endoscopic Visualization System Market The Asian endoscopy visualization equipment market, mainly driven by favorable reimbursements in select geographies, growing aging population, and increasing prevalence/incidence of diseases requiring endoscopy procedures, was valued at $2.70 million in 2013 and is expected to reach $3.85 million by 2018, growing at a CAGR of 7.4% during the forecast period. The report on this market analyzes the market by segments that include endoscopic cameras, video processors, video converters, camera heads, endoscopic light sources, transmitters and receivers, wireless displays and monitors, and other visualization devices. The key players in this market are Stryker Corporation, Ethicon Endo-Surgery, Inc., Olympus Corporation, Covidien plc, Arthrex, Inc., Smiths Group plc, Aesculap, Inc., ConMed Corporation, Richard Wolf GmbH, Hoya Corporation, Boston Scientific Corporation, and Fujifilm Holdings Corporation. |
Upcoming |
